|
| Effect of Shenkang injection combined with hemodialysis treatment on nutriture levels in patients with end stage renal disease |
| Hits 1385 Download times 1100 Received:May 26, 2018 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1672-1519.2018.11.05 |
| Key Words
chronic renal failure;Shenkang injection;hemodialysis;nutritional status |
| Author Name | Affiliation | E-mail | | CHEN Jianjun | Blood Purification Center, Nanjing First Hospital, Nanjing 210006, China | | | ZHOU Yue | Blood Purification Center, Nanjing First Hospital, Nanjing 210006, China | 56005460@qq.com | | LOU Jizhuang | Blood Purification Center, Nanjing First Hospital, Nanjing 210006, China | | | YANG Jiangsheng | Blood Purification Center, Nanjing First Hospital, Nanjing 210006, China | |
|
| Abstract
|
| [Objective] To study the effect of Shenkang injection combined with hemodialysis treatment on nutriture levels in patients with (end stage renal disease).[Methods] A total of 120 patients with (end stage renal disease) who received hemodialysis treatment in our hospital were selected and randomly divided into two groups, the observation group received Shenkang injection treatment in the process of dialysis, and the control group only received hemodialysis. The 8 weeks after treatment, serum was collected to determine the levels of renal function indexes,nutritional status indexes, electrolyte and traditional Chinese medicine(TCM) syndrome, evaluate the curative effect and record the adverse drug reactions.[Results] After treatment, the level of RBC, HGB, TP, ALB and the total efficiency of TCM syndrome in the control group was 83.33%. The treatment group was better than the control group (P<0.05). Compared with before treatment, the renal function and nutritional status, electrolyte related indicators and TCM syndromes of the two groups were significantly changed after treatment (P<0.05). There were no abnormalities in the routine tests.[Conolusion] Shenkang injection combined with hemodialysis treatment helps to improve electrolyte, has good safety in patients with end stage renal disease. |
|
|
|
|
|
|
|
